论文部分内容阅读
难治性心力衰竭是临床多见而棘手问题之一。洋地黄类、利尿剂、扩血管药和某些β-受体兴奋剂乃是目前主要的治疗方法,但在某些重症病例仍难以奏效。氨利酮(Amrinone)及同类药物米利酮
Refractory heart failure is one of the more common and difficult problems in clinical practice. Digitalis, diuretics, vasodilators and certain beta-agonists are the mainstay of treatment today, but are still ineffective in some critically ill cases. Amrinone and the same drug milrinone